Literature DB >> 6353237

Insulin-like growth factors I and II, prolactin, and insulin in 19 growth hormone-deficient children with excessive, normal, or decreased longitudinal growth after operation for craniopharyngioma.

H Bucher, J Zapf, T Torresani, A Prader, E R Froesch, R Illig.   

Abstract

We studied insulin-like growth factors (IGF) I and II, prolactin, and the insulin response to arginine in 19 children with craniopharyngioma and documented growth hormone deficiency. Patients were divided into three groups according to their growth rate during the first postoperative year. Seven patients with excessive growth (Group A) had hyperinsulinism, normal IGF values, elevated basal prolactin levels, and a delayed thyrotropin response to thyrotropin-releasing hormone, which was compatible with hypothalamic lesions. In the six patients with normal growth (Group B), the insulin level was low; all other hormone values were similar to those of Group A. In the six patients with decreased growth (Group C), levels of IGF I, insulin, prolactin, and thyrotropin were low, indicating the presence of severe pituitary damage and explaining the failure to grow. Patients in all groups had low or undetectable basal levels of growth hormone. We conclude that in Group B, normal IGF permitted normal growth, and prolactin hypersecretion may have been responsible for normal IGF I values. Excessive growth in Group A may have been caused by hyperinsulinism associated with hyperphagia and obesity of hypothalamic origin.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6353237     DOI: 10.1056/NEJM198311103091902

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  15 in total

1.  Hyperinsulinemia may promote growth without GH in children after resection of suprasellar brain tumors.

Authors:  Hideyuki Iwayama; Takashi Kamijo; Norishi Ueda
Journal:  Endocrine       Date:  2011-06-03       Impact factor: 3.633

Review 2.  The role of the central melanocortin system in the regulation of food intake and energy homeostasis: lessons from mouse models.

Authors:  Kate L J Ellacott; Roger D Cone
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2006-07-29       Impact factor: 6.237

3.  Insulin-like growth factors in lysosomal storage disease.

Authors:  S E Jaeggi-Groisman; W Kiess; H Christomanou; U Kessler; E R Froesch
Journal:  Eur J Pediatr       Date:  1992-01       Impact factor: 3.183

4.  Proliferative retinopathy in a woman with growth hormone deficiency and diabetes mellitus.

Authors:  C H Thivolet; P Mirakian; P Chatelain; P Fournier; J Tourniaire
Journal:  BMJ       Date:  1990-04-14

5.  Polymorphisms of diacylglycerol acyltransferase 2 gene and their relationship with growth traits in goats.

Authors:  Xingtang Fang; Jingmin Zhang; Haixia Xu; Chunlei Zhang; Yu Du; Xiuying Shi; Danxia Chen; Jiajie Sun; Qijiang Jin; Xianyong Lan; Hong Chen
Journal:  Mol Biol Rep       Date:  2011-06-04       Impact factor: 2.316

6.  Effect of growth hormone on short normal children.

Authors:  P C Hindmarsh; C G Brook
Journal:  Br Med J (Clin Res Ed)       Date:  1987-09-05

Review 7.  [Principles and clinical significance of insulin-like growth factors/somatomedins].

Authors:  E Weimann; W Kiess
Journal:  Klin Wochenschr       Date:  1990-10-17

8.  Long-term endocrine effects and trends in body mass index changes in patients with childhood-onset brain tumors.

Authors:  Go Hun Seo; Jin-Ho Choi; Yoon-Myung Kim; Kyung-Nam Koh; Ho Joon Im; Young Shin Ra; Han-Wook Yoo
Journal:  J Neurooncol       Date:  2018-01-19       Impact factor: 4.130

9.  Circulating levels of growth hormone, insulin-like growth factor-I and prolactin in normal, growth retarded and anencephalic human fetuses.

Authors:  M Arosio; D Cortelazzi; L Persani; E Palmieri; G Casati; A M Baggiani; G Gambino; P Beck-Peccoz
Journal:  J Endocrinol Invest       Date:  1995-05       Impact factor: 4.256

10.  Excessive growth in a child with craniopharyngioma and growth hormone deficiency.

Authors:  J M Wit; A Schuitema-Dijkstra; S van Buul-Offers; F Opmeer; J L Van den Brande
Journal:  Eur J Pediatr       Date:  1988-08       Impact factor: 3.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.